Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.9%

2 terminated out of 34 trials

Success Rate

92.6%

+6.1% vs benchmark

Late-Stage Pipeline

41%

14 trials in Phase 3/4

Results Transparency

20%

5 of 25 completed with results

Key Signals

5 with results93% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (6)
P 2 (5)
P 3 (8)
P 4 (6)

Trial Status

Completed25
Unknown3
Terminated2
Not Yet Recruiting1
Active Not Recruiting1
Recruiting1

Trial Success Rate

92.6%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT06526884Not ApplicableActive Not Recruiting

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

NCT06299215CompletedPrimary

Factors and Prognosis of Obstructive Pyelonephritis Patients

NCT07070102Not Yet RecruitingPrimary

Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children

NCT06802796CompletedPrimary

Plasma NGAL in APN Patients

NCT03959163Not ApplicableRecruitingPrimary

The Validity of the Quick Renal MRI in Pediatric Kidney Disease

NCT04594161Not ApplicableCompleted

Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis

NCT06128213Phase 2Unknown

NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis

NCT02598362Phase 4Completed

Pharmacokinetics of Ciprofloxacin in Pediatric Patients

NCT03230838Phase 2Completed

MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)

NCT00948779Not ApplicableCompleted

Antibiotic Education for Children in an Emergency Care Unit

NCT01861353Not ApplicableCompleted

Cranberry-lingonberry Juice Started During Acute Infection in Prevention of Urinary Tract Infections in Children

NCT03282006Phase 4CompletedPrimary

Treating Pyelonephritis an Urosepsis With Pivmecillinam

NCT03275623Phase 4Completed

Management of Sub-Clinical Bacteriuria in Pregnancy

NCT01505634Phase 2Completed

Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003)

NCT03873701Completed

Bedside Ultrasonography in Acute Patients With Suspected Kidney Involvement

NCT02728089Phase 3Completed

Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)

NCT01345929Phase 3Completed

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis

NCT02080182Phase 2CompletedPrimary

Effect of Acetylcysteine in Pediatric Acute Pyelonephritis.

NCT02246361Phase 4Completed

Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication

NCT01771432Not ApplicableUnknown

Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria

Scroll to load more

Research Network

Activity Timeline